Litcius/Paper detail

Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients

Fedor Hlebokazov, T. Dakukina, Michael P. Potapnev, С. М. Космачева, Lubov Moroz, Nikolai Misiuk, Tatiana S. Golubeva, E.L. Slobina, О. V. Krasko, Antos Shakhbazau, Ivan Hlavinski, Н. В. Гончарова

2021Clinical Neurology and Neurosurgery49 citationsDOI

Topics & Concepts

MedicineLevetiracetamConcomitantMesenchymal stem cellEpilepsyClinical trialDepression (economics)Internal medicineSurgeryAnesthesiaPathologyPsychiatryMacroeconomicsEconomicsMesenchymal stem cell researchEpilepsy research and treatmentNeurogenesis and neuroplasticity mechanisms
Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients | Litcius